Dr. Maly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3991 Dutchmans Ln
Ste 405
Louisville, KY 40207Phone+1 502-899-3366Fax+1 502-629-2055
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2017- Ohio State University HospitalResidency, Internal Medicine, 2011 - 2014
Lewis Katz School of Medicine at Temple UniversityClass of 2011
Certifications & Licensure
KY State Medical License 2017 - 2026
IN State Medical License 2017 - 2025
OH State Medical License 2011 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection Start of enrollment: 2020 Aug 14
- A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms Start of enrollment: 2020 Dec 21
Publications & Presentations
PubMed
- A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML.Guillermo Garcia-Manero, James McCloskey, Elizabeth A Griffiths, Karen W L Yee, Amer M Zeidan
Future Oncology. 2025-03-06 - 13 citationsPertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free SurvivalJoseph J. Maly, Erin Macrae
Breast Cancer. 2014-05-12 - 110 citationsIncidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumabErin M. Olson, Mahmoud Abdel-Rasoul, Joseph Maly, Christina Wu, Nan Lin
Annals of Oncology. 2013-06-01
Abstracts/Posters
- Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b StudyClinically Relevant AbstractJoseph Maly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...Joseph Maly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
